Updates to Molecular Pathology Codes for BRCA1, BRCA2 (May 2019)

Why This Topic Matters

BRCA1 and BRCA2 testing is commonly used in hereditary cancer evaluation, so coding updates can affect laboratory reporting, claim accuracy, and compliance. Understanding the revised molecular pathology structure helps stakeholders align documentation and test reporting with the current CPT framework.

Article Sections

1. Molecular Pathology

   Overview of the CPT molecular pathology updates affecting BRCA1 and BRCA2 testing. Covers the restructuring of the code family, related parenthetical guidance, and examples of how the article organizes the updated reporting categories.

2. Clinical Example (81162) / Description of Procedure (81162)

   Illustrative scenario and procedural overview associated with one BRCA1/BRCA2 testing category. Focuses on the type of laboratory workflow and testing context addressed in the article.

3. Clinical Example (81163) / Description of Procedure (81163)

   Illustrative scenario and procedural overview associated with a BRCA testing category focused on sequence analysis. Provides context for the laboratory methods discussed in the article.

4. Clinical Example (81164) / Description of Procedure (81164)

   Illustrative scenario and procedural overview associated with a BRCA testing category focused on duplication/deletion analysis. Describes the kind of laboratory work referenced in the article.

5. Clinical Example (81165) / Description of Procedure (81165)

   Illustrative scenario and procedural overview associated with a BRCA1-specific testing category. Highlights the clinical and laboratory context used to explain the update.

6. Clinical Example (81166) / Description of Procedure (81166)

   Illustrative scenario and procedural overview associated with a BRCA1 duplication/deletion category. Shows how the article presents the updated testing structure in practice.

7. Clinical Example (81167) / Description of Procedure (81167)

   Illustrative scenario and procedural overview associated with a BRCA2 duplication/deletion category. Provides the final example used to illustrate the code revisions.

8. Reference

   Citation information supporting the article's discussion of BRCA1 and BRCA2 molecular pathology updates.